Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FBXW7 |
Variant | D550Mfs*6 |
Impact List | frameshift |
Protein Effect | unknown |
Gene Variant Descriptions | FBXW7 D550Mfs*6 indicates a shift in the reading frame starting at amino acid 550 and terminating 6 residues downstream causing a premature truncation of the 707 amino acid Fbxw7 protein (UniProt.org). D550Mfs*6 has been identified in sequencing studies (PMID: 26960398), but has not been biochemically characterized and therefore, its effect on Fbxw7 protein function is unknown (PubMed, Feb 2025). |
Associated Drug Resistance | |
Category Variants Paths |
FBXW7 mutant FBXW7 D550Mfs*6 |
Transcript | NM_033632.3 |
gDNA | chr4:g.152324391delC |
cDNA | c.1648delG |
Protein | p.D550Mfs*6 |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
XM_011532085 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_011532085.2 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_011532084.2 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_047415900.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_011532084.3 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_011532084 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_047415901.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_011532085.3 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_047415899.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
NM_033632 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_024454124.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
NM_033632.3 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
NM_001349798.2 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_024454122.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
NM_001349798.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_024454121.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_047415898.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_024454123.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_047415897.1 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_011532083 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_024454123.2 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
XM_017008362 | chr4:g.152324391delC | c.1648delG | p.D550Mfs*6 | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
FBXW7 mutant | Her2-receptor negative breast cancer | predicted - sensitive | LY3039478 | Case Reports/Case Series | Actionable | In a Phase I trial, LY3039478 treatment resulted in partial response lasted 9.5 months in a patient with hormone receptor-positive, Erbb2 (Her2)-negative breast cancer harboring FBXW7 mutation (PMID: 30060061; NCT01695005). | 30060061 |